Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Microbiosci Introduces New Bacillus subtilis 168 Knockout Strains

    Jan 2, 2024, 09:12 AM by
    Full story
  • Creative Biogene Unveils Stable Cell Lines for Use in ADCC and ADCP Cellular Assays

    Jan 2, 2024, 09:12 AM by
    Full story
  • Empower Your Research with Creative Proteomics' Innovative Pull-Down Assay Service

    Jan 2, 2024, 09:12 AM by
    Full story
  • Creative Proteomics Launches Label-free Quantification Service for Advanced Protein Analysis

    Jan 2, 2024, 09:12 AM by
    Full story
  • Creative Proteomics Launches Innovative Ubiquitinated Proteomics Service for Advanced Research

    Jan 2, 2024, 09:12 AM by
    Full story
  • Creative Enzymes Unleashes Revolutionary Trypsin-Chymotrypsin, Elevating Protease Research to New Heights

    Jan 2, 2024, 09:12 AM by
    Full story
  • Creative Enzymes Releases Microorganism-Derived Bilirubin Oxidase

    Jan 2, 2024, 09:12 AM by
    Full story
  • CD Formulation Extends Holiday Greetings for 2023 with an Exclusive Discount

    Jan 2, 2024, 09:12 AM by
    Full story
  • Alfa Chemistry Launches Varieties of Biological Reagents for Use in Nucleic Acid Purification Systems

    Jan 2, 2024, 09:12 AM by
    Full story
  • Huateng Pharma Introduces Versatile Ingredients for Cosmetics and Commodities

    Jan 2, 2024, 09:12 AM by
    Huateng Pharma introduces Tetrahydrocurcumin, a dual-action antioxidant and skin-whitening agent, alongside Pro-xylane and (S)-Pro-xylane, potent anti-ageing agents, and Piroctone Olamine, an effective anti-dandruff solution, emphasizing a commitment to quality and versatility from lab to commercial scale.
    Full story
  • Amerigo Scientific Highlights Cell-Free Expression Supplies with pEU Vector Set

    Jan 2, 2024, 09:12 AM by
    Full story
  • BOC Sciences and Spaya Join Forces to Expand Chemical Offerings

    Jan 2, 2024, 09:06 AM by
    BOC Sciences, a leading chemical supplier, has partnered with Spaya, an AI-powered chemical synthesis platform, to enhance the portfolio of commercially available materials by listing an unprecedented 140,000+ chemical products.
    Full story
  • Andelyn Biosciences Selected by Ultragenyx for Late-Stage Process Performance Qualification (PPQ) Manufacturing of Novel Gene Therapy for Sanfilippo Syndrome

    Jan 2, 2024, 09:06 AM by
    Columbus, OH, December 18, 2023 - Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced that it has been selected by Ultragenyx (NASDAQ: RARE) to perform late-stage Process Performance Qualification (PPQ) manufacturing of the company’s UX111 gene therapy for the potential treatment of Sanfilippo Syndrome (MPS IIIA).
    Full story
  • Genomenon Launches Classification Service, Medidata’s New Research Alliance, New Devices, Platforms, More

    Dec 28, 2023, 01:00 AM by User Not Found
    Bio-IT World | Genomenon launched Genomenon Curate-Pro variant classification service; Medidata launches the Medidata Research Alliance; Edinburgh Innovations has announced a novel 3D printed device that could replace the need for drug and chemical safety testing on animals; and more.
    Full story
  • Follow the Money: AI For Drug Discovery, Small Molecule Therapeutics, Multi-Omics Platform for Women’s Reproductive Immunotherapies, More

    Dec 27, 2023, 01:00 AM by User Not Found
    Bio-IT World | Sanofi enters a multi-year research collaboration with French pharmatech company Aqemia; Apple Tree Partners will expand its portfolio company Deep Apple Therapeutics to rapidly discover novel small molecule therapeutics for high-value targets through virtual screening of AI-generated virtual libraries; Freya Biosciences intends to advance their multi-omics data science platform; and more.
    Full story
  • ‘Reverse Metabolomics’ Enables Biological Discoveries From Repository Data

    Dec 21, 2023, 01:00 AM by User Not Found
    Bio-IT World | In a turnaround of the usual metabolomics study approach, University of California San Diego scientists are homing in on the microbial-produced molecules that interact with cells and affect human health. A couple million such molecules are likely awaiting discovery in this fashion.
    Full story
  • Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the Analysis of Neuromelanin-sensitive MRI

    Dec 20, 2023, 09:15 AM by
    Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the Analysis of Neuromelanin-sensitive MRI
    Full story
  • Alfa Chemistry Unveils Its Cosmetic and Personal Care Product Testing Capabilities

    Dec 20, 2023, 09:15 AM by
    Full story
  • Stability Analysis Plays a Crucial Role in Pharmaceutical Formulation, Highlighted by CD Formulation

    Dec 20, 2023, 09:15 AM by
    Full story
  • AppOmni Unveils First AI SaaS Security Posture Management Assistant, AskOmni, Redefining SaaS Security and Usability

    Dec 20, 2023, 09:15 AM by
    AppOmni, SaaS Security Posture Management (SSPM) leader and SaaS security pioneer, today unveiled a groundbreaking advancement with the introduction of AskOmni. This first AI-powered SSPM assistant developed by the AppOmni OmniScience team propels SSPM into new dimensions, simplifying security operations and issue remediation, and helping organizations secure mission-critical SaaS environments.
    Full story
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69 (current)
  • 70
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy